跳转至内容
Merck
CN

858811

Sigma-Aldrich

5-溴-2′-脱氧尿苷

97%

别名:

5-BrdU, 5-溴-1-(2-脱氧-β-D-呋喃核糖)尿嘧啶, 5-溴脱氧尿苷, BUdR

登录查看公司和协议定价

选择尺寸

关于此项目

经验公式（希尔记法）:
C9H11BrN2O5
化学文摘社编号:
59-14-3
分子量:
307.10
Beilstein:
30395
EC 号:
200-415-9
MDL编号:
MFCD00006529
UNSPSC代码:
41106305
PubChem化学物质编号:
24888474

主要文件

查看所有文档
技术服务
需要帮助？我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助？我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

方案

97%

旋光性

[α]22/D +23.0°, c = 1 in H2O

mp

191-194 °C (dec.) (lit.)

储存温度

−20°C

SMILES字符串

OC[C@H]1O[C@H](C[C@@H]1O)N2C=C(Br)C(=O)NC2=O

InChI

1S/C9H11BrN2O5/c10-4-2-12(9(16)11-8(4)15)7-1-5(14)6(3-13)17-7/h2,5-7,13-14H,1,3H2,(H,11,15,16)/t5-,6+,7+/m0/s1

InChI key

WOVKYSAHUYNSMH-RRKCRQDMSA-N

正在寻找类似产品? 访问 产品对比指南

生化/生理作用

用作遗传研究中诱变剂的胸苷类似物。在 S 期可选择性结合到细胞 DNA 中。

象形图

Health hazard
GHS08

警示用语：

Danger

危险声明

H340,H361fd

危险分类

Muta. 1B - Repr. 2

储存分类代码

6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects

WGK

WGK 2

个人防护装备

Eyeshields, Gloves, type N95 (US)

法规信息

新产品
此项目有

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number
02731MH
08313JH
08713JH
11723JB
11423JB

没有发现合适的版本？

如果您需要特殊版本，可通过批号或批次号查找具体证书。

搜索COA

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

  1. Which document(s) contains shelf-life or expiration date information for a given product?

    If available for a given product, the recommended re-test date or the expiration date can be found on the Certificate of Analysis.

  2. How do I get lot-specific information or a Certificate of Analysis?

    The lot specific COA document can be found by entering the lot number above under the "Documents" section.

  3. How do I find price and availability?

    There are several ways to find pricing and availability for our products. Once you log onto our website, you will find the price and availability displayed on the product detail page. You can contact any of our Customer Sales and Service offices to receive a quote.  USA customers:  1-800-325-3010 or view local office numbers.

  4. What is the stability of Product 858811, 5-Bromo-2´-deoxyuridine (BrdU)?

    The comparable Sigma product, B5002, has a recommended retest specification of 2 years. We have observed by TLC that the material is unchanged after 3 years. Solutions at neutral pH should be stable if stored frozen for up to 6 months.

  5. What can I use to detect BrdU, 5-Bromo-2´-deoxyuridine, in vivo and in vitro?

    For the immunohistochemical detection of BrdU, we recommend the monoclonal anti-BrdU antibody, Product No. B2531.

  6. What are the hazards associated with Product 858811, 5-Bromo-2´-deoxyuridine (BrdU)?

    BrdU is a known carcinogen, and caution should be exercised when handling. Please refer to the MSDS.

  7. How long do I treat cells with Product 858811, 5-Bromo-2´-deoxyuridine (BrdU) to incorporate it into the DNA?

    Actively growing cells may be treated with 10 μM BrdU for 1 hour.

  8. How does Product 858811, 5-Bromo-2´-deoxyuridine (BrdU), work as a thymidine analog?

    BrdU replaces thymidine during the S-phase of cell division.

  9. What is the Department of Transportation shipping information for this product?

    Transportation information can be found in Section 14 of the product's (M)SDS.To access the shipping information for this material, use the link on the product detail page for the product. 

  10. My question is not addressed here, how can I contact Technical Service for assistance?

    Ask a Scientist here.

Mark R Dowling et al.
Proceedings of the National Academy of Sciences of the United States of America, 111(17), 6377-6382 (2014-04-16)
Stochastic variation in cell cycle time is a consistent feature of otherwise similar cells within a growing population. Classic studies concluded that the bulk of the variation occurs in the G1 phase, and many mathematical models assume a constant time
Linda Helbig et al.
International journal of radiation oncology, biology, physics, 88(1), 159-166 (2013-12-18)
To study the effects of BAY-84-7296, a novel orally bioavailable inhibitor of mitochondrial complex I and hypoxia-inducible factor 1 (HIF-1) activity, on hypoxia, microenvironment, and radiation response of tumors. UT-SCC-5 and UT-SCC-14 human squamous cell carcinomas were transplanted subcutaneously in nude
Y-F Tan et al.
Frontiers in neuroscience, 5, 59-59 (2011-05-05)
Ionizing radiation continues to be a relevant tool in both imaging and the treatment of cancer. Experimental uses of focal irradiation have recently been expanded to studies of new neurons in the adult brain. Such studies have shown cognitive deficits
Stéphane Chevrier et al.
The Journal of experimental medicine, 211(5), 827-840 (2014-04-09)
The transcriptional network regulating antibody-secreting cell (ASC) differentiation has been extensively studied, but our current understanding is limited. The mechanisms of action of known "master" regulators are still unclear, while the participation of new factors is being revealed. Here, we
Hiroyuki Hosokawa et al.
Proceedings of the National Academy of Sciences of the United States of America, 110(46), 18626-18631 (2013-10-30)
GATA-binding protein 3 (Gata3) controls the differentiation of naive CD4 T cells into T helper 2 (Th2) cells by induction of chromatin remodeling of the Th2 cytokine gene loci, direct transactivation of Il5 and Il13 genes, and inhibition of Ifng.
查看所有相关文献

我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持